Arka India Feeder LP has filed an amendment to its private equity fund offering, which is significant for its ongoing fundraising efforts. The amendment, filed on November 10, 2026, indicates the company's proactive approach to enhancing its investment strategies.
The company is classified as a limited partnership and is based in Mauritius. It operates under the auspices of Viroha Capital Private Ltd, which serves as its executive officer. The firm has been active in the private equity sector, focusing on pooled investment funds.
The filing, with accession number 0001671735-26-000002, highlights the offering's compliance with Rule 506(b) and the Investment Company Act Section 3(c). This amendment is part of a series of filings, with the previous one submitted on November 6, 2025. The company has indicated that the total offering amount is indefinite, with $10,000 already sold.
This update may affect investors interested in private equity opportunities, particularly as Arka India Feeder LP has indicated it accepts non-accredited investors. The company has also set a minimum investment of $500,000 for potential investors.
The filing does not say what happens next, leaving future developments regarding the offering open-ended.
Additional Details from the Filing
The amendment also confirms that Arka India Feeder LP is classified as a pooled investment fund, specifically a private equity fund, and is not subject to the Investment Company Act under the 40 Act. The company has indicated that it has been in operation for over five years, with the date of the first sale of securities recorded as November 19, 2015.
Furthermore, the filing reveals that the total number of investors who have already invested is one, with no non-accredited investors currently participating. The company has stated that the offering duration is expected to exceed one year, allowing for a prolonged fundraising period.
Interestingly, the filing also notes that there are no sales commissions or finders' fees associated with the offering, which may appeal to potential investors looking for cost-effective investment opportunities.
"The total offering amount remains indefinite, with $10,000 sold to date, indicating a cautious approach to fundraising while maintaining flexibility in capital acquisition."
Read Next
Organo Corporation registers 25 million ADS in SEC filing
JPMorgan Chase Financial Co. announces new equity notes
WE Select Fund 4, L.P. files new offering under Rule 506(b)
Fannie Mae Updates SEC Filing on Asset-Backed Securities
JPMorgan Chase Financial Co. LLC Issues $1.12M Callable Notes
Scimeca Dario files to sell 2,821 shares of Precision BioSciences




